Cormorant Asset Management Lp

Top Portfolio
Top Buys
Top Sells
New Buys
Exits
Corbus Pharmaceuticals Holdings, Inc.
CRBP
$79.46M18.952.02MNew+$79.46M3.77
MoonLake Immunotherapeutics
MLTX
$426.66M13.38.49M0%+$020.22
EyePoint Pharmaceuticals, Inc.
EYPT
$142.48M13.246.89M+14.16%+$17.67M6.75
Helix Acquisition Corp. II Class A Ordinary Shares
HLXB
$30.25M12.652.91MNew+$30.25M1.43
Immuneering Corporation
IMRX
$9.52M11.113.3M-21.62%-$2.63M0.45
Biomea Fusion, Inc.
BMEA
$53.38M9.933.57M0%+$02.53
Longboard Pharmaceuticals, Inc.
LBPH
$72.43M8.623.35M+42.5%+$21.6M3.43
Praxis Precision Medicines, Inc.
PRAX
$79.94M7.661.31M+106.84%+$41.29M3.79
ALX Oncology Holdings Inc.
ALXO
$35.03M6.033.14M0%+$01.66
Marinus Pharmaceuticals, Inc.
MRNS
$29.38M5.923.25M0%+$01.39
Korro Bio, Inc.
KRRO
$47.63M5.71529,1700%+$02.26
Tarsus Pharmaceuticals, Inc.
TARS
$77.76M5.662.14M-3.71%-$2.99M3.69
Tourmaline Bio, Inc.
TRML
$28.63M4.871.25MNew+$28.63M1.36
Neurogene Inc.
NGNE
$27.42M4.15538,714-27.8%-$10.56M1.3
Compass Therapeutics, Inc.
CMPX
$11.01M4.045.56MNew+$11.01M0.52
Ventyx Biosciences, Inc.
VTYX
$14.9M3.842.71MNew+$14.9M0.71
Aerovate Therapeutics, Inc.
AVTE
$31.63M3.711.07M-11.71%-$4.2M1.5
Arcellx, Inc.
ACLX
$123.8M3.331.78M+4.71%+$5.56M5.87
Edgewise Therapeutics, Inc.
EWTX
$54.84M3.223.01M+17.81%+$8.29M2.6
Pharvaris N.V.
PHVS
$39.55M3.181.71M0%+$01.87
CARGO Therapeutics, Inc. Common Stock
CRGX
$26.39M31.18M0%+$01.25
Autolus Therapeutics plc
AUTL
$42.21M2.496.62M+21.41%+$7.44M2
Astria Therapeutics, Inc.
ATXS
$18.3M2.371.3MNew+$18.3M0.87
Cabaletta Bio, Inc.
CABA
$18.77M2.281.1MNew+$18.77M0.89
Mersana Therapeutics, Inc.
MRSN
$11.65M2.132.6MNew+$11.65M0.55
Nkarta, Inc.
NKTX
$14.59M1.921.35MNew+$14.59M0.69
Arcutis Biotherapeutics, Inc.
ARQT
$21.06M1.842.13MNew+$21.06M1
BridgeBio Pharma, Inc.
BBIO
$99.04M1.713.2M-4.22%-$4.36M4.69
ArriVent BioPharma, Inc. Common Stock
AVBP
$9.2M1.54515,000New+$9.2M0.44
Crinetics Pharmaceuticals, Inc.
CRNX
$53.83M1.461.15M0%+$02.55
Janux Therapeutics, Inc.
JANX
$28.24M1.45750,000New+$28.24M1.34
Silence Therapeutics plc
SLN
$13.5M1.34625,000New+$13.5M0.64
Merus N.V.
MRUS
$32.2M1.22715,000New+$32.2M1.53
CG Oncology, Inc. Common stock
CGON
$35.12M1.2800,000New+$35.12M1.66
GH Research PLC
GHRS
$6.32M1.14593,0430%+$00.3
Kyverna Therapeutics, Inc. Common Stock
KYTX
$10.93M1.02440,000New+$10.93M0.52
Rhythm Pharmaceuticals, Inc.
RYTM
$23.83M0.9550,0000%+$01.13
Stoke Therapeutics, Inc.
STOK
$5.77M0.82427,163-60.73%-$8.92M0.27
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$33.74M0.7616,963+652.73%+$29.26M1.6
Vaxcyte, Inc.
PCVX
$46.79M0.63685,000+3.01%+$1.37M2.22
Spyre Therapeutics, Inc.
SYRE
$9.48M0.62250,000-73.32%-$26.06M0.45
IDEAYA Biosciences, Inc.
IDYA
$19.75M0.6450,0000%+$00.94
Disc Medicine, Inc.
IRON
$7.78M0.51125,0000%+$00.37
Centessa Pharmaceuticals plc
CNTA
$6.35M0.5561,6000%+$00.3
Verve Therapeutics, Inc.
VERV
$4.65M0.42350,0000%+$00.22
Insmed Incorporated
INSM
$15.6M0.39575,0000%+$00.74
Rocket Pharmaceuticals, Inc.
RCKT
$8.08M0.33300,000-33.33%-$4.04M0.38
Apellis Pharmaceuticals, Inc.
APLS
$23.51M0.33400,000-36%-$13.23M1.11
Lantheus Holdings, Inc.
LNTH
$4.67M0.1175,0000%+$00.22
Abivax SA American Depositary Shares
ABVX
$30.46M<0.012.13M0%+$01.44